COMMUNIQUÉS West-GlobeNewswire

Plus Products: Top-Ranked Edibles in California -- CFN Media

01/11/2018 - 14:00

SEATTLE, Nov. 01, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]

ATW Tech Closes the Sale of its Atman Assets for $1.3 Million

01/11/2018 - 14:00

MONTREAL, Nov. 01, 2018 (GLOBE NEWSWIRE) -- ATW Tech Inc. (TSX-V: ATW) announces today the closing of the sale of its Psychometric Research and Services of Atman assets (“Atman”), previously announced on September 17, [...]

ATW Tech conclut la vente des actifs d’Atman pour 1,3 million

01/11/2018 - 14:00

MONTRÉAL, 01 nov. 2018 (GLOBE NEWSWIRE) -- ATW Tech Inc. (la « Société » ou « ATW Tech ») (TSX-V : ATW) annonce aujourd’hui la clôture de la vente de ses actifs des Services et Recherche Psychométrique d‘Atman (« Atman [...]

GBT Announces Upcoming Data Presentations at 60th American Society of Hematology (ASH) Annual Meeting & Exposition

01/11/2018 - 14:00

Company to Present Three Oral Presentations, Including Results Beyond 12 Weeks from Part A of the HOPE Study Company to Host Investor Webcast on Monday, December 3 SOUTH SAN FRANCISCO, Calif., Nov. 01, 2018 (GLOBE [...]

Terra Tech Corp. Makes Strategic Investment in Leading Hydroponics Provider

01/11/2018 - 13:41

IRVINE, Calif., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Terra Tech Corp. (OTCQX: TRTC), (“Terra Tech” or the “Company”) a vertically integrated cannabis-focused agriculture company, is pleased to announce that it has made a $ [...]

Onconova Therapeutics, Inc. to Provide Corporate Update and Third Quarter 2018 Financial Results

01/11/2018 - 13:30

Company to Hold Conference Call and Webcast at 9:00 a.m. Eastern Time on Tuesday, November 13, 2018 NEWTOWN, Pa., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX) , a Phase 3-stage [...]

Eyenovia Announces Conference Call and Webcast for Third Quarter 2018 Financial Results

01/11/2018 - 13:30

NEW YORK, Nov. 01, 2018 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a biopharmaceutical company developing a pipeline of ophthalmology products utilizing its patented piezo-print technology to deliver microdosed [...]

ChemoCentryx to Hold Third Quarter 2018 Financial Results Conference Call on Thursday, November 8, 2018

01/11/2018 - 13:30

MOUNTAIN VIEW, Calif., Nov. 01, 2018 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that the Company's third quarter 2018 financial results will be released after market close on Thursday, [...]

Daxor Corporation Initiates Strategic Collaboration with CHF Solutions, Inc. to Manage Patients with Fluid Overload

01/11/2018 - 13:30

NEW YORK, Nov. 01, 2018 (GLOBE NEWSWIRE) -- DAXOR CORPORATION ( NYSE MKT: DXR ) announced today that it has entered into an agreement with CHF Solutions (Nasdaq: CHFS) to explore clinical synergies between the company’s [...]

Vericel to Present at the Canaccord Genuity Medical Technologies & Diagnostic Forum

01/11/2018 - 13:30

CAMBRIDGE, Mass., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced cell therapies for the sports medicine and severe burn care markets, today announced that Nick Colangelo, [...]

Sirona Dx Introduces Imaging Mass Cytometry Services to Advance Biomarker Discovery and Therapeutic Development

01/11/2018 - 13:30

Specialized CRO offers high-definition tissue imaging services for pharmaceutical and clinical research SOUTH SAN FRANCISCO, Calif. and PORTLAND, Ore., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Sirona Dx, a leader in high- [...]

Viveve to Host Conference Call to Discuss Third Quarter 2018 Financial and Operating Results

01/11/2018 - 13:28

ENGLEWOOD, Colo., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Viveve Medical, Inc. (NASDAQ: VIVE), a medical technology company focused on women's intimate health, today announced that it will report financial results for the [...]

Clinical Genomics and Quest Diagnostics extend collaboration to provide InSure® ONE™, a fecal immunochemical test for colorectal cancer screening programs

01/11/2018 - 13:18

Relationship ensures broad access to innovative FIT test in the U.S. BRIDGEWATER, N.J., and SECAUCUS, N.J., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Clinical Genomics, a leading innovator of tests for colorectal cancer, and [...]

111, Inc. to Announce Third Quarter 2018 Financial Results on November 8, 2018

01/11/2018 - 13:16

SHANGHAI, China, Nov. 01, 2018 (GLOBE NEWSWIRE) -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading integrated online and offline healthcare platform in China, today announced that it will report its unaudited [...]

LIDDS presence at BIO-Europe 2018 to focus on NanoZolid's broad drug formulation capability

01/11/2018 - 13:15

At BIO-Europe 2018, LIDDS will be meeting potential licensing and collaborative partners, to discuss the recently announced pre-clinical studies with NanoZolid-technology. The STING study is yet another proof point of [...]

Director/PDMR Shareholding

01/11/2018 - 13:15

DXS INTERNATIONAL PLC Director Dealing The Board of DXS International plc (the “Company”), the NEX quoted clinical decision support developer and supplier of clinical decision support systems is pleased to confirm that [...]

Novan Publication Supports Women’s Health Business Unit Initiative and Nitric Oxide’s Potential Against HPV-Associated Diseases

01/11/2018 - 13:05

Data from SB206 Phase 2 clinical trial in external genital warts have been published in the Journal of Drugs in Dermatology SB206 was efficacious and well tolerated in the trial Advancement of the late stage clinical [...]

Evolus to Participate in Two Upcoming Investor Conferences

01/11/2018 - 13:01

IRVINE, Calif., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ:EOLS), a company dedicated to aesthetic medicine, announced today that members of management will be participating in two upcoming investor [...]

Intra-Cellular Therapies to Host Third Quarter 2018 Financial Results Conference Call and Webcast

01/11/2018 - 13:00

NEW YORK, Nov. 01, 2018 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI) a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today announced [...]